June 6, 2024

Webinar: Innovation in Medicine: Exploring the Potential of human Platelet Lysate

Online

Discover the applications and advancements of human platelet lysate in our upcoming webinar, presented by the European Blood Alliance’s Working Group on Innovation and New Products. Scheduled for June 6 from 13:00 to 14:30 CEST, this session will dive into the significant role that human platelet lysate plays in modern medical practices and research.

The webinar will feature expert insights from leaders in the field, including Ólafur Eysteinn Sigurjónsson, Hendrik Feys, Katharina Schallmoser, Erja Kerkelä, and David Lundy. Topics will cover the standardization of human platelet lysate, regulatory considerations, good manufacturing practices for advanced therapy medicinal product (ATMP) manufacturing, and innovative treatments for hypoxic injuries.

Join us for a series of keynote presentations followed by a panel discussion and an interactive Q&A session where you can pose your questions directly to the experts. Specifically, this event is particularly suited for medical researchers and clinical practitioners (EBA Members), and regulatory affairs professionals who are keen to understand and engage with the latest developments across various medical domains.

Register now to gain valuable insights into the cutting-edge applications of human platelet lysate and its implications for healthcare innovation.

Register here

Once your registration is approved, you will receive an email confirmation with the link to join the webinar.

Detailed Programme

 

13:00 Opening

Peter O’Leary, Executive Director European Blood Alliance

13:05 Introduction

Ólafur Eysteinn Sigurjónsson, Head of Research and Development, Icelandic Blood Bank and Chair of EBA Innovation and New Products Working Group

13:15 Keynote Presentations
  Towards standardized human Platelet Lysate

Hendrik Feys, Principal Investigator, Red Cross Flanders

  Regulatory aspects

Katharina Schallmoser, Professor for Transfusion Medicine, Paracelsus Medical University of Salzburg, Austria

  Example of GMP production for ATMP manufacturing

Erja Kerkelä, Development Manager, Finnish Red Cross Blood Service

  Treatment of hypoxic injuries

David Lundy, Associate Professor, Taipei Medical University

14:15 Panel Discussion and Q&A
  Q&A session, allowing participants to engage directly with the experts
14:35 Closing

 

More events

Expand the map
  • 20 million donations
  • 446 million population
ES PT GR LT DK MT IT DE SE NO FI EE LV CH HU FR GB NL HR SI AT MK IE IS BE LU